FAct: A Non-interventional Multi-center Study to Follow Patients Starting With RoActemra Assessing the Long Term Efficacy, Effectiveness and Safety of RoActemra.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 May 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms FACT
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 25 Sep 2013 Planned End Date changed from 1 Dec 2017 to 1 Feb 2017 as reported by ClinicalTrials.gov.
- 26 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.